Literature DB >> 25756434

Are new oral anticoagulant dosing recommendations optimal for all patients?

J Robert Powell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25756434     DOI： 10.1001/jama.2015.59

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban.

Authors:  Ruijuan Xu; Weihong Ge; Qing Jiang
Journal:  Eur J Clin Pharmacol       Date:  2018-02-17       Impact factor: 2.953

2.  Incomplete Resolution of Deep Vein Thromboses during Rivaroxaban Therapy.

Authors:  Jonathan M Yaghoubian; Jacob Adashek; Bahareh Yaghoubian-Yazi; Menachem Nagar; Nojan Toomari; Richard J Pietras; Uri M Ben-Zur
Journal:  Case Rep Cardiol       Date:  2017-07-30

3.  Development of New Deep Venous Thrombosis While on Apixaban.

Authors:  Munish Sharma; Sabarina Ramanathan; Koroush Khalighi
Journal:  Case Rep Cardiol       Date:  2017-06-20

4.  Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants.

Authors:  Sophie Testa; Cristina Legnani; Emilia Antonucci; Oriana Paoletti; Claudia Dellanoce; Benilde Cosmi; Vittorio Pengo; Daniela Poli; Rossella Morandini; Roberto Testa; Armando Tripodi; Gualtiero Palareti
Journal:  J Thromb Haemost       Date:  2019-05-26       Impact factor: 5.824

5.  Rivaroxaban in acute venous thromboembolism: UK prescribing experience.

Authors:  Victoria Speed; Jignesh P Patel; Derek Cooper; Stephen Miller; Lara N Roberts; Raj K Patel; Roopen Arya
Journal:  Res Pract Thromb Haemost       Date:  2021-10-21

Review 6.  Dodging blood brain barrier with "nano" warriors: Novel strategy against ischemic stroke.

Authors:  Suhel Parvez; Medha Kaushik; Mubashshir Ali; Mohammad Mumtaz Alam; Javed Ali; Heena Tabassum; Pooja Kaushik
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

Review 7.  Warfarin: The End or the End of One Size Fits All Therapy?

Authors:  Munir Pirmohamed
Journal:  J Pers Med       Date:  2018-06-28

8.  The impact of body weight on rivaroxaban pharmacokinetics.

Authors:  Sarah J Barsam; Jignesh P Patel; Lara N Roberts; Venu Kavarthapu; Raj K Patel; Bruce Green; Roopen Arya
Journal:  Res Pract Thromb Haemost       Date:  2017-10-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.